Crunching the numbers for ARWR... Refresh in a moment for the full analysis.
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Healthcare
mixed
$65.14
Updated: 2026-04-12
58
TradeApes Score
hold
Financial Strength
65
Healthy
Operating Trend
85
Strong
Valuation
30
Weak
Capital Allocation
30
Weak
Risk
80
Strong
Key Findings
+
Strong revenue growth — sales up more than 20% year over year
−
Extreme P/E — above 45×, very high expectations embedded in price
See the full analysis
Quarterly financials, DCF valuation model, Watchlist, and Stock Screener.
Create Free Account
Scores and valuations are model outputs, not investment advice. TradeApes does not provide financial, tax, or investment advice.